SBI Hires Merck Exec to Head Drug Discovery Efforts | GenomeWeb

NEW YORK, Jan 5 – Proteomics company Structural Bioinformatics said Friday it has appointed Ian McDonald as vice president of drug discovery.

McDonald was previously senior director of chemistry at Merck Research Laboratories. He is an inventor on 32 patents in the US.

" Over the past few years, SBI has consistently demonstrated its unique ability to efficiently generate initial hits from in silico screening of virtual libraries against modeled protein structures,” McDonald said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.